As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
If your healthcare provider prescribes Ozempic, you will give yourself a subcutaneous injection (under the skin of the upper arm, thigh, or stomach) once a week using a prefilled pen
If the side effects persist, your health care provider may prescribe a different medication that supports blood sugar control and weight loss
6, June 2017, pp
it happened in parallel to me buckling down and trying to lose weight